You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • 12.03 ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38 positive hematological malignancies

Article metrics

Article menu

Download PDFPDF

Oral Presentations
Plenary symposium 12: combination therapy (with a special focus on local IO)
12.03 ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38 positive hematological malignancies
Free

 

Online download statistics by month:

Online download statistics by month: September 2022 to September 2024

AbstractFullPdf
Sep 20225805
Oct 2022110016
Nov 202212805
Dec 20224607
Jan 20232207
Feb 20233006
Mar 20232608
Apr 20232005
May 20232801
Jun 20232805
Jul 20232606
Aug 20232402
Sep 20232209
Oct 20234008
Nov 20233606
Dec 20234207
Jan 20242003
Feb 20243608
Mar 20243202
Apr 20242204
May 20241202
Jun 20242203
Jul 20244804
Aug 20241405
Sep 20241001
Total9020135